Your position:m.limatoxi.com>>EN>>EN>>Pharmaceutical News>>In the first half of 2024, the penicillin series of Sinopharm Group Wichita Pharmaceutical Co., Ltd. increased substantially, reducing the output of cephalosporin series.>> article
In the first half of 2024, the penicillin series of Sinopharm Group Wichita Pharmaceutical Co., Ltd. increased substantially, reducing the output of cephalosporin series.
Editor:xuezhe Clicks:0Date:2024/8/30 15:36:27
Keyword:cephalosporin
Healthoo Information:
In the first half of 2024, the penicillin series of Sinopharm Group Wichita Pharmaceutical Co., Ltd. increased substantially, reducing the output of cephalosporin series.
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • Import Export Analysis of Indian Cephalosporin API Intermediates in th...
  • Changes of international trade in import export of cephalosporin APIs ...
  • In the first half of 2023, Indias cephalosporin exports increased by 4...
  • Changes in international trade of Indian cephalosporin raw materials
  • Market Analysis of Cephalosporins Penicillins
  • Market Analysis of Penicillin Cephalosporin Raw Materials
  • Xinquan to build cephalosporin intermediates project
  • Cephalosporins sale rank in sample drug stores in Jun. 2020
  • India exporters of Cephalosporin APIs& Intermediates in 1st half of 20...
  • India export statistics of Cephalosporin APIs& Intermediates in 1st ha...
    		•
    Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map